Wicab
WI - FitchburgBiotechnology
Focus: Wicab is a mid-cap medical device company specializing in sensory substitution technology, transforming neural signals into tactile feedback to restore function in blind and vestibular-impaired patients. With 1,001-5,000 employees and headquarters in Fitchburg, WI, the company operates as a public entity focused on niche high-impact neurological indications.
Profile data last refreshed Yesterday · AI intelligence enriched 2w ago
Funding Stage
PUBLIC
Employees
1001-5000
Open Jobs
0
About Wicab
AI assessmentNot HiringNo open roles listed right now. Follow Wicab to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
7 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Key Products
BrainPort Vision Pro
Stable
Growth
Flagship sensory substitution device leveraging electrotactile feedback to enable spatial perception in blind patients; represents core commercialization proof of concept.
BrainPort Balance Device
Help build intelligence for Wicab
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.